Apolipoprotein(a) phenotypes as genetic markers of coronary atherosclerosis severity

被引:22
作者
Gazzaruso, C [1 ]
Geroldi, D
Garzaniti, A
Falcone, C
Fratino, P
Finardi, G
Buscaglia, P
机构
[1] Univ Pavia, Policlin San Matteo, IRCCS,Dept Internal Med & Med Therapeut, Sect Internal Med Vasc & Metab Dis, I-27100 Pavia, Italy
[2] Univ Pavia, Policlin San Matteo, IRCCS, Div Cardiol, I-27100 Pavia, Italy
[3] Univ Pavia, Sect Internal Med, Polo Univ Convenzionato Citta Pavia, I-27100 Pavia, Italy
关键词
apolipoprotein(a) polymorphism; atherosclerosis; coronary disease; lipoprotein(a);
D O I
10.1016/S0167-5273(98)00050-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated Lp(a) levels and apo(a) polymorphism in relation to the severity of coronary artery disease, expressed both by the number of coronary arteries stenosed and three different coronary scoring systems. In a sample of 267 patients with coronary artery disease, a Mono-, Bi- or Multi-vessel coronary stenosis was documented by angiography. Twenty-five apo(a) isoforms were detected by a high resolution phenotyping method. Lp(a) levels did not show any differences among subgroups of patients. Both the percentage of apo(a) isoforms of low molecular weight (<655 kDa) (P=0.00015) and the percentage of subjects with at least one apo(a) isoform of low molecular weight (P=0.00027) were significantly correlated with increasing number of coronary vessels stenosed. In multivariate analysis, only apo(a) isoforms of low molecular weight were predictors of coronary atherosclerosis severity, when we used as the dependent variable both the '1-2-multi-vessels' categorization (P=0.000067) and the Gensini (P=0.008767), or Green Lane (P=0.000001) or Dahlen (P=0.000102) coronary scoring system. Our data show that apo(a) isoforms of low molecular weight are associated with a greater severity of coronary atherosclerosis. If these data are confirmed by prospective studies, apo(a) phenotypes might be used as genetic markers of a greater severity of coronary atherosclerotic lesions. (C) 1998 Elsevier Science Ireland Ltd.
引用
收藏
页码:277 / 284
页数:8
相关论文
共 38 条
  • [11] CLINICAL-SIGNIFICANCE OF EXERCISE-INDUCED SILENT-MYOCARDIAL-ISCHEMIA IN PATIENTS WITH CORONARY-ARTERY DISEASE
    FALCONE, C
    DESERVI, S
    POMA, E
    CAMPANA, C
    SCIRE, A
    MONTEMARTINI, C
    SPECCHIA, G
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (02) : 295 - 299
  • [12] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
  • [13] Gazzaruso C, 1996, J Cardiovasc Risk, V3, P191, DOI 10.1097/00043798-199604000-00010
  • [14] Gazzaruso C, 1996, NUTR METAB CARDIOVAS, V6, P203
  • [15] Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension
    Gazzaruso, C
    Buscaglia, P
    Garzaniti, A
    Falcone, C
    Mariotti, S
    Savino, S
    Bonetti, G
    Finardi, G
    Geroldi, D
    [J]. JOURNAL OF HYPERTENSION, 1997, 15 (03) : 227 - 235
  • [16] CHARACTERIZATION OF APO(A) POLYMORPHISM BY A MODIFIED IMMUNOBLOTTING TECHNIQUE IN AN ITALIAN POPULATION-SAMPLE
    GEROLDI, D
    BELLOTTI, V
    BUSCAGLIA, P
    BONETTI, G
    GAZZARUSO, C
    CAPRIOLI, A
    FRATINO, P
    [J]. CLINICA CHIMICA ACTA, 1993, 221 (1-2) : 159 - 169
  • [17] HARRIS M, 1979, DIABETES, V28, P1039
  • [18] PREDICTIVE VALUE OF LIPOPROTEIN (A) AND OTHER SERUM-LIPOPROTEINS IN THE ANGIOGRAPHIC DIAGNOSIS OF CORONARY-ARTERY DISEASE
    HEARN, JA
    DEMAIO, SJ
    ROUBIN, GS
    HAMMARSTROM, M
    SGOUTAS, D
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (17) : 1176 - 1180
  • [19] LIPOPROTEIN LP(A) - A RISK FACTOR FOR MYOCARDIAL-INFARCTION
    HOEFLER, G
    HARNONCOURT, F
    PASCHKE, E
    MIRTL, W
    PFEIFFER, KH
    KOSTNER, GM
    [J]. ARTERIOSCLEROSIS, 1988, 8 (04): : 398 - 401
  • [20] KAMBOH MI, 1991, AM J HUM GENET, V49, P1063